CORDAREX

Cordarex Adverse Events Reported to the FDA Over Time

How are Cordarex adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cordarex, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cordarex is flagged as the suspect drug causing the adverse event.

Most Common Cordarex Adverse Events Reported to the FDA

What are the most common Cordarex adverse events reported to the FDA?

Renal Failure Acute	29 (4.52%)
Drug Interaction	15 (2.34%)
Nausea	13 (2.03%)
Tubulointerstitial Nephritis	13 (2.03%)
Hepatitis Acute	11 (1.72%)
Multi-organ Failure	10 (1.56%)
Shock	10 (1.56%)
Bradycardia	9 (1.4%)
Interstitial Lung Disease	9 (1.4%)
Left Ventricular Failure	9 (1.4%)
Small Intestinal Perforation	9 (1.4%)
	Show More
Aspartate Aminotransferase Increase...	8 (1.25%)
Hyperthyroidism	8 (1.25%)
Loss Of Consciousness	8 (1.25%)
Renal Failure	8 (1.25%)
Alveolitis	7 (1.09%)
Dizziness	7 (1.09%)
Alanine Aminotransferase Increased	6 (.94%)
Apnoea	6 (.94%)
Blood Lactate Dehydrogenase Increas...	6 (.94%)
Hypothyroidism	6 (.94%)
Lung Disorder	6 (.94%)
Vomiting	6 (.94%)
Weight Decreased	6 (.94%)
Atrial Fibrillation	5 (.78%)
Blood Pressure Increased	5 (.78%)
Chest Pain	5 (.78%)
Convulsion	5 (.78%)
Gamma-glutamyltransferase Increased	5 (.78%)
Heart Rate Increased	5 (.78%)
Hyperkalaemia	5 (.78%)
Hyponatraemia	5 (.78%)
Long Qt Syndrome	5 (.78%)
Lung Infiltration	5 (.78%)
Pancreatitis Acute	5 (.78%)
Paraesthesia	5 (.78%)
Tachycardia	5 (.78%)
Torsade De Pointes	5 (.78%)
Blood Creatine Phosphokinase Increa...	4 (.62%)
Blood Creatinine Increased	4 (.62%)
Cardiac Failure	4 (.62%)
Condition Aggravated	4 (.62%)
Drug Ineffective	4 (.62%)
Fatigue	4 (.62%)
Gastrointestinal Haemorrhage	4 (.62%)
General Physical Health Deteriorati...	4 (.62%)
Heart Rate Decreased	4 (.62%)
Infusion Related Reaction	4 (.62%)
Muscle Spasms	4 (.62%)
Pneumonia Primary Atypical	4 (.62%)
Pulmonary Hypertension	4 (.62%)
Retching	4 (.62%)
Acute Respiratory Distress Syndrome	3 (.47%)
Anaemia	3 (.47%)
Blood Alkaline Phosphatase Increase...	3 (.47%)
Constipation	3 (.47%)
Dehydration	3 (.47%)
Diarrhoea	3 (.47%)
Drug Effect Decreased	3 (.47%)
Eyelid Oedema	3 (.47%)
Haemoglobin Decreased	3 (.47%)
Hepatic Failure	3 (.47%)
Hepatocellular Injury	3 (.47%)
Hepatotoxicity	3 (.47%)
Injection Site Erythema	3 (.47%)
Injection Site Necrosis	3 (.47%)
Injection Site Vesicles	3 (.47%)
Nephrogenic Anaemia	3 (.47%)
Pneumonitis	3 (.47%)
Pulmonary Fibrosis	3 (.47%)
Pulmonary Oedema	3 (.47%)
Renal Failure Chronic	3 (.47%)
Rhabdomyolysis	3 (.47%)
Abdominal Pain	2 (.31%)
Acute Hepatic Failure	2 (.31%)
Ageusia	2 (.31%)
Arrhythmia	2 (.31%)
Asthenia	2 (.31%)
Blister	2 (.31%)
Blood Pressure Decreased	2 (.31%)
Blood Pressure Diastolic Increased	2 (.31%)
Blood Urea Increased	2 (.31%)
Brain Natriuretic Peptide Increased	2 (.31%)
Bronchitis Chronic	2 (.31%)
Cardioactive Drug Level Decreased	2 (.31%)
Circulatory Collapse	2 (.31%)
Clostridium Colitis	2 (.31%)
Cough	2 (.31%)
Death	2 (.31%)
Diabetes Mellitus	2 (.31%)
Dyspnoea	2 (.31%)
Escherichia Infection	2 (.31%)
Flatulence	2 (.31%)
Gastrointestinal Disorder	2 (.31%)
General Physical Condition Abnormal	2 (.31%)
Glutamate Dehydrogenase Increased	2 (.31%)
Groin Pain	2 (.31%)
Haemodialysis	2 (.31%)
Haemoptysis	2 (.31%)
Haemorrhagic Erosive Gastritis	2 (.31%)
Haemorrhoidal Haemorrhage	2 (.31%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Cordarex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cordarex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cordarex

What are the most common Cordarex adverse events reported to the FDA?

Renal Disorders	42 (6.55%)
Lower Respiratory Tract Disorders	38 (5.93%)
Cardiac Arrhythmias	36 (5.62%)
Hepatic And Hepatobiliary	30 (4.68%)
Gastrointestinal Signs	29 (4.52%)
Respiratory	27 (4.21%)
Hepatobiliary	25 (3.9%)
Neurological	24 (3.74%)
Therapeutic And Nontherapeutic Effe...	22 (3.43%)
Cardiac And Vascular Investigations	20 (3.12%)
Administration Site Reactions	17 (2.65%)
	Show More
Enzyme	15 (2.34%)
Heart Failures	15 (2.34%)
Decreased And Nonspecific Blood Pre...	14 (2.18%)
Infections - Pathogen Unspecified	14 (2.18%)
Nephropathies	14 (2.18%)
Thyroid Gland	14 (2.18%)
Electrolyte And Fluid Balance Condi...	13 (2.03%)
Epidermal And Dermal Conditions	13 (2.03%)
Gastrointestinal Ulceration And Per...	11 (1.72%)
Muscle	11 (1.72%)
Bacterial Infectious	9 (1.4%)
Physical Examination Topics	8 (1.25%)
Exocrine Pancreas Conditions	7 (1.09%)
Renal And Urinary Tract Investigati...	7 (1.09%)
Anemias Nonhemolytic And Marrow Dep...	6 (.94%)
Gastrointestinal Motility And Defec...	6 (.94%)
Seizures	6 (.94%)
Hematology Investigations	5 (.78%)
Metabolic, Nutritional And Blood Ga...	5 (.78%)
Ocular Structural Change, Deposit A...	5 (.78%)
Gastrointestinal Hemorrhages	4 (.62%)
Medication Errors	4 (.62%)
Pulmonary Vascular	4 (.62%)
Tongue Conditions	4 (.62%)
Bronchial Disorders	3 (.47%)
Fatal Outcomes	3 (.47%)
Hematological And Lymphoid Tissue T...	3 (.47%)
Musculoskeletal And Connective Tiss...	3 (.47%)
Neuromuscular	3 (.47%)
Ocular Infections, Irritations And ...	3 (.47%)
Peripheral Neuropathies	3 (.47%)
Body Temperature Conditions	2 (.31%)
Gallbladder	2 (.31%)
Gastrointestinal Conditions	2 (.31%)
Gastrointestinal Vascular Condition...	2 (.31%)
Glucose Metabolism Disorders	2 (.31%)
Lifestyle Issues	2 (.31%)
Ocular Hemorrhages And Vascular	2 (.31%)
Oral Soft Tissue Conditions	2 (.31%)
Protein And Amino Acid Metabolism	2 (.31%)
Renal And Urinary Tract Neoplasms M...	2 (.31%)
Respiratory And Pulmonary Investiga...	2 (.31%)
Skin And Subcutaneous Tissue	2 (.31%)
Skin Vascular Abnormalities	2 (.31%)
Toxicology And Therapeutic Drug Mon...	2 (.31%)
Anal And Rectal Conditions	1 (.16%)
Angiedema And Urticaria	1 (.16%)
Appetite And General Nutritional	1 (.16%)
Arteriosclerosis, Stenosis, Vascula...	1 (.16%)
Cardiac Disorder Signs	1 (.16%)
Cardiac Therapeutic Procedures	1 (.16%)
Cardiac Valve	1 (.16%)
Chemical Injury And Poisoning	1 (.16%)
Chlamydial Infectious	1 (.16%)
Cognitive And Attention Disorders	1 (.16%)
Connective Tissue Disorders	1 (.16%)
Cornification And Dystrophic Skin	1 (.16%)
Coronary Artery	1 (.16%)
Depressed Mood Disorders	1 (.16%)
Endocrine Investigations	1 (.16%)
Fungal Infectious	1 (.16%)
Gastrointestinal	1 (.16%)
Injuries By Physical Agents	1 (.16%)
Investigations, Imaging And Histopa...	1 (.16%)
Joint	1 (.16%)
Lipid Metabolism	1 (.16%)
Metabolism	1 (.16%)
Movement Disorders	1 (.16%)
Neurological Disorders Of The Eye	1 (.16%)
Peritoneal And Retroperitoneal Cond...	1 (.16%)
Pleural	1 (.16%)
Procedural And Device Related Injur...	1 (.16%)
Protein And Chemistry Analyses	1 (.16%)
Renal And Urinary Tract Neoplasms B...	1 (.16%)
Respiratory And Mediastinal Neoplas...	1 (.16%)
Skin Appendage Conditions	1 (.16%)
Structural Brain	1 (.16%)
Vascular	1 (.16%)
Vision	1 (.16%)
Water, Electrolyte And Mineral	1 (.16%)
White Blood Cell	1 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cordarex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cordarex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.